133 related articles for article (PubMed ID: 38380977)
1. Exploring the cytotoxicity of dinuclear Ru(II)
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
[TBL] [Abstract][Full Text] [Related]
2. Naphthoyl benzhydrazine-decorated binuclear arene Ru(II) complexes as anticancer agents targeting human breast cancer cells.
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Grzegorz Małecki J
Dalton Trans; 2023 Nov; 52(44):16376-16387. PubMed ID: 37870147
[TBL] [Abstract][Full Text] [Related]
3. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
4. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract][Full Text] [Related]
5. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
6. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
7. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
8. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
10. Ru(II)-
Dorairaj DP; Haribabu J; Dharmasivam M; Malekshah RE; Mohamed Subarkhan MK; Echeverria C; Karvembu R
Inorg Chem; 2023 Jul; 62(30):11761-11774. PubMed ID: 37459067
[TBL] [Abstract][Full Text] [Related]
11. Dinuclear Organoruthenium Complex for Mitochondria-Targeted Near-Infrared Imaging and Anticancer Therapy to Overcome Platinum Resistance.
Wang J; Zhang Y; Li Y; Li E; Ye W; Pan J
Inorg Chem; 2022 May; 61(21):8267-8282. PubMed ID: 35584546
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic Activities of New η
Ywaya DO; Ibrahim H; Friedrich HB; Bala MD; Soobramoney L; Daniels A; Singh M
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474456
[TBL] [Abstract][Full Text] [Related]
13. Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells.
Saha A; Mondal I; Kumari A; Sonkar AK; Mishra R; Kulshreshtha R; Patra AK
Dalton Trans; 2024 Jan; 53(4):1551-1567. PubMed ID: 38164612
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, theoretical, molecular docking and
Musthafa M; Konakanchi R; Ganguly R; Balachandran C; Aoki S; Sreekanth A
J Biomol Struct Dyn; 2021 Aug; 39(12):4346-4361. PubMed ID: 32597724
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
[TBL] [Abstract][Full Text] [Related]
20. Solution equilibrium, structural and cytotoxicity studies on Ru(η
Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
